Genomic abnormalities in chronic lymphocytic leukemia influence gene expression by a gene dosage effect

International Journal of Molecular Medicine

Volumn 17, Issue 5, 2006, Pages 769-778

  Dickinson, John D ^a   Joshi, Avadhut ^a   Iqbal, Javeed ^a   Sanger, Warren ^b   Bierman, Philip J ^a   Joshi, Shantaram S ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Chronic lymphocytic leukemia; Genomic abnormalities

Indexed keywords

ADULT; AGED; ARTICLE; CHROMOSOME 11; CHROMOSOME 12; CHROMOSOME 13; CHROMOSOME ABERRATION; CHROMOSOME BANDING PATTERN; CHROMOSOME DELETION; CHRONIC LYMPHATIC LEUKEMIA; CLUSTER ANALYSIS; DNA MICROARRAY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DOSAGE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HUMAN; KARYOTYPING; MALE; MIDDLE AGED; PATHOLOGY; SURVIVAL; TRISOMY;

ADULT; AGED; AGED, 80 AND OVER; CHROMOSOME ABERRATIONS; CHROMOSOME BANDING; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 12; CHROMOSOMES, HUMAN, PAIR 13; CLUSTER ANALYSIS; FEMALE; GENE DOSAGE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; LEUKEMIA, LYMPHOCYTIC, CHRONIC; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SURVIVAL ANALYSIS; TRISOMY;

EID: 33750604336     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.17.5.769     Document Type: Article

References (42)

1. Dighiero G: Perspectives in chronic lymphocytic leukemia biology and management. Hematol Oncol Clin North Am 18: 927-943, 2004. (Pubitemid 39119833)
2. Keating MJ, Chiorazzi N, Messmer B, Damle RN, Allen SL, Rai KR, Ferrarini M and Kipps TJ: Biology and treatment of chronic lymphocytic leukemia. Hematology (Am Soc Hematol Educ Program): 153-175, 2003.
3. Caligaris-Cappio F and Hamblin TJ: B-cell chronic lymphocytic leukemia: a bird of a different feather. J Clin Oncol 17: 399-408, 1999. (Pubitemid 29022419)
4. Di Giuseppe JA and Borowitz MJ: Clinical utility of flow cytometry in the chronic lymphoid leukemias. Semin Oncol 25: 6-10, 1998.
5. Catovsky D: Definition and diagnosis of sporadic and familial chronic lymphocytic leukemia. Hematol Oncol Clin North Am 18: 783-794, 2004. (Pubitemid 39119824)
6. Kay NE, Hamblin TJ, Jelinek DF, Dewald GW, Byrd JC, Farag S, Lucas M and Lin T: Chronic lymphocytic leukemia. Hematology (Am Soc Hematol Educ Program): 193-213, 2002.
7. Dewald GW, Brockman SR, Paternoster SF, et al: Chromosome anomalies detected by interphase fluorescence in situ hybridization: correlation with significant biological features of B-cell chronic lymphocytic leukaemia. Br J Haematol 121: 287-295, 2003.
8. Dohner H, Stilgenbauer S, Dohner K, et al: Chromosome aberrations in B-cell chronic lymphocytic leukemia: reassessment based on molecular cytogenetic analysis. J Mol Med 77: 266-281, 1999. (Pubitemid 29146578)
9. Gahrton G, Robert KH, Friberg K, et al: Non-random chromosomal aberrations in chronic lymphocytic leukemia revealed by polyclonal B-cell-mitogen stimulation. Blood 56: 640-647, 1980. (Pubitemid 10005668)
10. Juliusson G and Gahrton G: Cytogenetics in CLL and related disorders. Baillieres Clin Haematol 6: 821-848, 1993.
11. Dohner H, Stilgenbauer S, Benner A, et al: Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 343: 1910-1916, 2000.
12. Dickinson JD, Smith LM, Sanger WG, et al: Unique gene expression and clinical characteristics are associated with the 11q23 deletion in chronic lymphocytic leukaemia. Br J Haematol 128: 460-471, 2005.
13. Aoun P, Blair HE, Smith LM, et al: Fluorescence in situ hybridization detection of cytogenetic abnormalities in B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma. Leuk Lymphoma 45: 1595-1603, 2004.
14. Altman DG: Practical Statistics for Medical Research. 1 edition. Chapman & Hall/CRC, New York, NY, p611, 1991.
15. Wu TD: Analysing gene expression data from DNA microarrays to identify candidate genes. J Pathol 195: 53-65, 2001.
16. Tusher VG, Tibshirani R and Chu G: Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 98: 5116-5121, 2001.
17. Shen Y, Iqbal J, Xiao L, et al: Distinct gene expression profiles in different B-cell compartments in human peripheral lymphoid organs. BMC Immunol 5: 20, 2004.
18. Mensink E, van de Locht A, Schattenberg A, et al: Quantitation of minimal residual disease in Philadelphia chromosome positive chronic myeloid leukaemia patients using real-time quantitative RT-PCR. Br J Haematol 102: 768-774, 1998.
19. Dickinson JDGJ, Iqbal J, Lynch JC, Chan J, Bierman PJ and Joshi SS: 11q22.3 deletion in B-CLL is specifically associated with bulky lymphadenopathy CD26, CCL17, and ZAP-70 expression but not reduced expression of adhesion/cell surface receptor molecules. Leuk Lymphoma 47: 231-244, 2006.
20. Stilgenbauer S, Liebisch P, James MR, et al: Molecular cytogenetic delineation of a novel critical genomic region in chromosome bands 11q22.3-923.1 in lymphoproliferative disorders. Proc Natl Acad Sci USA 93: 11837-11841, 1996.
21. Faderl S, Keating MJ, Do KA, et al: Expression profile of 11 proteins and their prognostic significance in patients with chronic lymphocytic leukemia (CLL). Leukemia 16: 1045-1052, 2002. (Pubitemid 34618843)
22. Haslinger C, Schweifer N, Stilgenbauer S, et al: Microarray gene expression profiling of B-cell chronic lymphocytic leukemia subgroups defined by genomic aberrations and VH mutation status. J Clin Oncol 22: 3937-3949, 2004.
23. Einhorn S, Burvall K, Juliusson G, et al: Molecular analyses of chromosome 12 in chronic lymphocytic leukemia. Leukemia 3: 871-874, 1989.
24. Alizadeh AA, Eisen MB, Davis RE, et al: Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403: 503-511, 2000.
25. Damle RN, Ghiotto F, Valetto A, et al: B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytes. Blood 99: 4087-4093, 2002.
26. Kitada S, Zapata JM, Andreeff M, et al: Bryostatin and CD40- ligand enhance apoptosis resistance and induce expression of cell survival genes in B-cell chronic lymphocytic leukaemia. Br J Haematol 106: 995-1004, 1999.
27. Segel GB, Woodlock TJ, Xu J, et al: Early gene activation in chronic leukemic B lymphocytes induced toward a plasma cell phenotype. Blood Cells Mol Dis 30: 277-287, 2003. (Pubitemid 36539429)
28. Hromas R, Collins S, Raskind W, et al: Hem-1, a potential membrane protein, with expression restricted to blood cells. Biochim Biophys Acta 1090: 241-244, 1991.
29. Dohner H, Fischer K, Bentz M, et al: p53 gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias. Blood 85: 1580-1589, 1995.
30. Fenaux P, Preudhomme C, Lai JL, et al: Mutations of the p53 gene in B-cell chronic lymphocytic leukemia: a report on 39 cases with cytogenetic analysis. Leukemia 6: 246-250, 1992.
31. Pettitt AR, Sherrington PD, Stewart G, et al: p53 dysfunction in B-cell chronic lymphocytic leukemia: inactivation of ATM as an alternative to TP53 mutation. Blood 98: 814-822, 2001.
32. Stankovic T, Weber P, Stewart G, et al: Inactivation of ataxia telangiectasia mutated gene in B-cell chronic lymphocytic leukaemia. Lancet 353: 26-29, 1999.
33. Stankovic T, Stewart GS, Fegan C, et al: Ataxia telangiectasia mutated-deficient B-cell chronic lymphocytic leukemia occurs in pregerminal center cells and results in defective damage response and unrepaired chromosome damage. Blood 99: 300-309, 2002.
34. Mertens D, Wolf S, Schroeter P, et al: Down-regulation of candidate tumor suppressor genes within chromosome band 13q14.3 is independent of the DNA methylation pattern in Bcell chronic lymphocytic leukemia. Blood 99: 4116-4121, 2002.
35. Van Everdink WJ, Baranova A, Lummen C, et al: RFP2, c13ORF1, and FAM10A4 are the most likely tumor suppressor gene candidates for B-cell chronic lymphocytic leukemia. Cancer Genet Cytogenet 146: 48-57, 2003.
36. Kapanadze B, Kashuba V, Baranova A, et al: A cosmid and cDNA fine physical map of a human chromosome 13q14 region frequently lost in B-cell chronic lymphocytic leukemia and identification of a new putative tumor suppressor gene, Leu5. FEBS Lett 426: 266-270, 1998.
37. Matsuda A, Suzuki Y, Honda G, et al: Large-scale identification and characterization of human genes that activate NF-kappaB and MAPK signaling pathways. Oncogene 22: 3307-3318, 2003.
38. McKinnon PJ: ATM and ataxia telangiectasia. EMBO Rep 5: 772-776, 2004.
39. Shiloh Y: ATM and related protein kinases: safeguarding genome integrity. Nat Rev Cancer 3: 155-168, 2003.
40. Fukao T, Kaneko H, Birrell G, et al: ATM is upregulated during the mitogenic response in peripheral blood mononuclear cells. Blood 94: 1998-2006, 1999.
41. Gueven N, Keating KE, Chen P, et al: Epidermal growth factor sensitizes cells to ionizing radiation by down-regulating protein mutated in ataxia-telangiectasia. J Biol Chem 276: 8884-8891, 2001.
42. Starczynski J, Simmons W, Flavell JR, et al: Variations in ATM protein expression during normal lymphoid differentiation and among B-cell-derived neoplasias. Am J Pathol 163: 423-432, 2003.